Johnson & Johnson (JNJ) Asset Utilization Ratio (2009 - 2026)
Johnson & Johnson (JNJ) posted Asset Utilization Ratio of 0.48 for Q1 2026, little changed sequentially from 0.48 in Q4 2025, and up 0.77% YoY from 0.48 in Q1 2025.
Johnson & Johnson (JNJ) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Johnson & Johnson (JNJ) has 18 years of Asset Utilization Ratio data on file, last reported at 0.48 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 0.77% year-over-year to 0.48 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.48 (up 0.77% YoY) and the FY2025 annual result came in at 0.5, down 2.8% from the prior year.
- Asset Utilization Ratio was little changed at 0.48 in Q1 2026 per JNJ's latest filing, from 0.48 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.51 in Q4 2023, with the low at 0.42 in Q2 2023.
- Average Asset Utilization Ratio over 5 years is 0.48, with a median of 0.48 recorded in 2025.
- Year-over-year, Asset Utilization Ratio fell 14.21% in 2023 and increased 19.32% in 2024.
- Johnson & Johnson's Asset Utilization Ratio stood at 0.47 in 2022, then climbed by 8.01% to 0.51 in 2023, then retreated by 2.91% to 0.5 in 2024, then slipped by 3.05% to 0.48 in 2025, then gained by 0.24% to 0.48 in 2026.
- Business Quant data shows JNJ's Asset Utilization Ratio at 0.48 in Q1 2026, 0.48 in Q4 2025, and 0.48 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 0.63 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.48 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 0.46 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 0.50 |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 0.50 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 0.41 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.52 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.12 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 0.48 |
| Dec 28, 2025 | 0.48 |
| Sep 28, 2025 | 0.48 |
| Jun 29, 2025 | 0.47 |
| Mar 30, 2025 | 0.48 |
| Dec 29, 2024 | 0.50 |
| Sep 29, 2024 | 0.49 |
| Jun 30, 2024 | 0.49 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.51 |
| Oct 1, 2023 | 0.47 |
| Jul 2, 2023 | 0.42 |
| Apr 2, 2023 | 0.42 |
| Jan 1, 2023 | 0.44 |
| Oct 2, 2022 | 0.47 |
| Jul 3, 2022 | 0.49 |
| Apr 3, 2022 | 0.49 |
| Oct 3, 2021 | 0.51 |
| Jul 4, 2021 | 0.51 |
| Apr 4, 2021 | 0.48 |